Session Details

[1PS-15]【J】Academic Drug Development Conference 2024

Wed. Nov 27, 2024 4:45 PM - 7:00 PM JST
Wed. Nov 27, 2024 7:45 AM - 10:00 AM UTC
Room 15(Marine Messe Fukuoka Hall B, 2F Meeting Room 1-2)
Organizer: Yoshiki Ikeda (Kyoto University), Teruyo Kato (Nagoya University)
In the field of academic drug discovery, the intellectual property on the academic side isn't just limited to the drugs themselves. Companies see value in unique drug targets, know-how, and Proof Of Concept (POC). However, academia doesn't seem to place much emphasis on these intellectual properties. They've somewhat reduced patents to a mere 'pre-paper formality'. This approach hinders the growth of open innovation, and right now, academic drug discovery is in need of a significant shift. In this symposium, we aim to delve deeply into the practical aspects of drug discovery without the barriers between companies and universities. We've invited promising speakers to foster the advancement of academic drug discovery, striving to establish a foundation for mutual support through the latest technologies and research.

[1PS-15-01]Evaluation and engineering of monoclonal antibodies using reconstituted cell-free protein synthesis

○Teruyo Kato1, Hideo Nakano1 (1. Nagoya Univ.)
Comment()

[1PS-15-02]Development of Novel Experimental Setup Beyond Traditional Test Tube Experiments and Practical Application to Drug Discovery

○Masahiko Yoshimura1 (1. Kyoto University)
Comment()

[1PS-15-03]GAOptimizer, an evolutionary algorithm based protein redesign method

○Shogo Nakano1 (1. University of Shizuoka)
Comment()

[1PS-15-04]Intracellular behavior of anticancer drugs at the molecular level using nanowire single live-cell endoscopy

○Tomoko Inose1,2,3 (1. Hakubi center, Kyoto University, 2. iCeMS, Kyoto University, 3. JST PRESTO)
Comment()

[1PS-15-05]Identification of pancreatic cancer stem cells and development of ablation therapy

○Osamu Sugahara1, Tsunaki Higa1, Keiichi I. Nakayama1 (1. Lab. Anticancer Strategies, Advanced Res. Inst., Inst. Sci. Tokyo)
Comment()

[1PS-15-06(1P-825)]Study of anticancer and antiviral properties of several derivatives of piperazine-substituted pyranopyridines

○Sona Buloyan1, Alexander Ivanov2 (1. Scientific Technological Center of Organic and Pharmaceutical Chemistry NAS RA, 2. Engelhardt Institute of Molecular Biology Russian Academy of Sciences)
Comment()

[1PS-15-07(1P-753)]Development of an AI-driven next-generation drug discovery system for infectious diseases

○Yuki Otani1,2, Yasunari Wakizaka1, Daisuke Koga1, Hirofumi Aso1, Hideyuki Shimizu1,2 (1. Dept. AI Systems Medicine, Tokyo Medical and Dental Univ., 2. Grad. School of Medical and Dental Science, Tokyo Medical and Dental Univ.)
Comment()

[1PS-15-08(1P-330)]Development of omics technology for supersulfides and its application to drug discovery research

○Shingo Kasamatsu1,2, Ayaka Kinno1, Somei Komae1, Chiharu Miura1, Takuma Owaki1, Mahiro Kuryu1, Jun-ichi Hishiyama2, Tomoaki Ida3, Hideshi Ihara1,2 (1. Dept. of Biol. Chem., Grad. Sch. of Sci., Osaka Metropolitan Univ., 2. Dept. of Biol. Sci., Grad. Sch. of Sci., Osaka Prefecture Univ., 3. Org. for Res. Promo., Osaka Metropolitan Univ.)
Comment()

[1PS-15-09(1P-366)]Interaction Analysis of Designable LNPs with Membrane-mimetic SUVs to Elucidate the Mechanism of Cell Tropism

○Kozue Furuya1, Shu Okumura1, Mitsuko Sugano1 (1. Toshiba Corporation)
Comment()

[1PS-15-10(1P-398)]Development of brain-targeting drug delivery system using small molecules that transiently control blood-brain barrier

○Saito Inoue1, Atsuya Shirono1, Jumpei Taguchi2, Satomi Tomita2, Takamitsu Hosoya2, Hiroyuki Takeda3, Keisuke Tachibana1, Masuo Kondoh1,4, Yasushi Fujio1,4, Yoshiaki Okada1,4 (1. Grad. Sch. Pharm. Sci., Osaka University, 2. Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 3. PROS, Ehime University, 4. Center for Infectious Disease Education and Research (CiDER), Osaka University)
Comment()

[1PS-15-11]Functional sites hidden in antibody molecules and new avenues for application

○Saeko Yanaka1 (1. I I R Tokyo Tech.)
Comment()

[1PS-15-12]Devilish protein engineering: “Protein Carving”

○Yoshiki Ikeda1 (1. iCeMS, Kyoto University)
Comment()